Why it hurts: researchers seek mechanisms of cancer pain.
Garber
Ken
K
D000138:Acidosis / Q000150:complications / Q000378:metabolism; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000077868:Atrasentan; D001859:Bone Neoplasms / Q000378:metabolism / Q000556:secondary; D004164:Diphosphonates / Q000494:pharmacology; D004195:Disease Models, Animal; D006023:Glycoproteins / Q000494:pharmacology; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D009369:Neoplasms / Q000150:complications / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D053244:Osteoprotegerin; D010146:Pain / Q000209:etiology / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D011759:Pyrrolidines; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor
D000700:Analgesics; D000970:Antineoplastic Agents; D004164:Diphosphonates; D006023:Glycoproteins; D007473:Ion Channels; D053244:Osteoprotegerin; D011759:Pyrrolidines; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human; D000077868:Atrasentan